Titan Pharmaceuticals Inc Strategic Asset Allocation Index
Titan Pharmaceuticals Inc strategic asset allocation index. Titan Pharmaceuticals Inc (TTNP) has a Strategic Asset Allocation Index of 13.5% as of September 2022. Strategic assets (PP&E of $481.00K plus long-term investments of $-) total $481.00K, measured against net assets of $3.55 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See TTNP net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Titan Pharmaceuticals Inc (2000–2021)
Strategic asset allocation index of Titan Pharmaceuticals Inc from 2000 to 2021. This chart shows how Titan Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 18 annual periods from 2000 to 2021. As of September 2022, the index stands at 13.5%, representing strategic assets of $481.00K against net assets of $3.55 Million USD. Check Titan Pharmaceuticals Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Titan Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2000–2021)
Titan Pharmaceuticals Inc strategic asset allocation index by year from 2000 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Titan Pharmaceuticals Inc from 2000 to 2021, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see TTNP market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 14.0% | $717.00K | $717.00K | $- | $5.14 Million | ▼ -7.5 pp |
| 2020 | 21.5% | $759.00K | $759.00K | $- | $3.53 Million | ▼ -63.2 pp |
| 2019 | 84.7% | $1.21 Million | $1.21 Million | $- | $1.43 Million | ▲ +73.1 pp |
| 2018 | 11.6% | $794.00K | $794.00K | $- | $6.83 Million | ▼ -57.8 pp |
| 2017 | 69.4% | $595.00K | $595.00K | $- | $857.00K | ▲ +63.1 pp |
| 2016 | 6.3% | $837.00K | $837.00K | $- | $13.19 Million | ▼ -8.6 pp |
| 2015 | 14.9% | $1.04 Million | $1.04 Million | $- | $6.99 Million | ▲ +0.2 pp |
| 2014 | 14.7% | $1.27 Million | $1.27 Million | $- | $8.61 Million | ▼ -13.1 pp |
| 2013 | 27.8% | $1.60 Million | $1.60 Million | $- | $5.76 Million | ▲ +12.6 pp |
| 2008 | 15.3% | $275.00K | $275.00K | $- | $1.80 Million | ▲ +13.8 pp |
| 2007 | 1.5% | $388.00K | $388.00K | $- | $26.59 Million | ▼ -2.5 pp |
| 2006 | 3.9% | $457.00K | $457.00K | $- | $11.65 Million | ▼ -0.8 pp |
| 2005 | 4.7% | $788.00K | $788.00K | $- | $16.60 Million | ▲ +1.8 pp |
| 2004 | 3.0% | $1.04 Million | $1.04 Million | $- | $34.95 Million | ▲ +1.3 pp |
| 2003 | 1.7% | $789.00K | $789.00K | $- | $45.67 Million | ▲ +0.4 pp |
| 2002 | 1.4% | $979.00K | $979.00K | $- | $71.98 Million | ▲ +0.8 pp |
| 2001 | 0.6% | $575.00K | $575.00K | $- | $101.37 Million | ▲ +0.1 pp |
| 2000 | 0.5% | $593.00K | $593.00K | $- | $115.98 Million | — |